BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Clinical Outcome
3 results:

  • 1. Detection of t(14;18), P53 and RAS gene mutations and quantification of residual disease in patients with B-cell non-Hodgkin's lymphoma.
    Cikota BM; Tukić LJ; Tarabar OT; Magić ZM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):535-42. PubMed ID: 18365550
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
    Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y
    Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. n-ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis.
    Lübbert M; Mirro J; Miller CW; Kahan J; Isaac G; Kitchingman G; Mertelsmann R; Herrmann F; McCormick F; Koeffler HP
    Blood; 1990 Mar; 75(5):1163-9. PubMed ID: 2407301
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.